Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial

Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial

Abstract Objective: Uptake of screening through the Australian National Bowel Cancer Screening Program remains low. General practice guidelines support the general practitioners’ role to offer CRC screening. This study tests the effect that an intervention including point‐of‐care FOBT provision, pri...

Full description

Bibliographic Details
Main Authors:	Natalie Dodd, Mariko Carey, Elise Mansfield, Christopher Oldmeadow, Tiffany‐Jane Evans
Format:	Article
Language:	English
Published:	Elsevier 2019-10-01
Series:	Australian and New Zealand Journal of Public Health
Subjects:	colorectal cancer faecal occult blood test general practice early detection of cancer randomised controlled trial
Online Access:	https://doi.org/10.1111/1753-6405.12913

Similar Items

Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics
by: Natalie Dodd, et al.
Published: (2018-08-01)

Identifying the factors promoting colorectal cancer screening uptake in Hong Kong using Andersen’s behavioural model of health services use
by: Dorothy N. S. Chan, et al.
Published: (2022-06-01)

The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies
by: Kearns B, et al.
Published: (2018-03-01)

Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening
by: Lasse Kaalby, et al.
Published: (2023-01-01)

The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care
by: Sibel Saya, et al.
Published: (2022-09-01)

Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial
by: Tom Treasure, et al.
Published: (2019-12-01)

A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey
by: Lindsay C. Kobayashi, et al.
Published: (2016-07-01)

Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia
by: Ian T. Zajac, et al.
Published: (2016-08-01)

Faecal tests in the early detection of colorectal cancer
by: Joanna Kowalik
Published: (2020-09-01)

POPULATION BASED COLORECTAL CANCER SCREENING: COMPARISON OF TWO FAECAL OCCULT BLOOD TESTS
by: Miren Begoña eZubero, et al.
Published: (2014-01-01)

Use of faecal immunochemical tests common in patients with suspected colorectal cancer but unrelated to travel distance to secondary care: a population-based study from Swedish primary care
by: Cecilia Högberg, et al.
Published: (2022-10-01)

Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study
by: Eva Lykke Toft, et al.
Published: (2019-04-01)

The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis
by: Fiona A. Ross, et al.
Published: (2022-04-01)

Co-designing planning interventions to facilitate participation in mail-out bowel cancer screening
by: Laura E. Anderson, et al.
Published: (2024-09-01)

Can a print‐based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial
by: Mariko Carey, et al.
Published: (2016-12-01)

Faecal immunochemical tests for the diagnosis of symptomatic colorectal cancer in primary care: the benefit of more than one sample
by: Cecilia Högberg, et al.
Published: (2017-10-01)

Impact of the faecal immunochemical test on colorectal cancer survival
by: María Angeles Gutierrez-Stampa, et al.
Published: (2020-07-01)

Colorectal Screening Program in Northern Portugal: First Findings
by: Hugo Monteiro, et al.
Published: (2022-03-01)

The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study
by: Amir Sadeghi, et al.
Published: (2023-07-01)

Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy
by: Takuji Kawamura, et al.
Published: (2020-10-01)

Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis
by: Nikos Papadimitriou, et al.
Published: (2024-01-01)

Colorectal cancer, screening: achievements и opportunities
by: E. A. Polyanskaya, et al.
Published: (2018-12-01)

A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
by: Oiana Telleria, et al.
Published: (2022-06-01)

Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening
by: Tim L. Kortlever, et al.
Published: (2021-09-01)

Evaluation of the Sentinel-FOB gold faecal immunochemical test for the presence of haemoglobin using the automated Roche Cobas 8000 system
by: Lutz Schwettmann, et al.
Published: (2022-03-01)

The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)—a randomised controlled trial
by: Jayne Digby, et al.
Published: (2020-10-01)

Correction to the article “Colorectal Screening Program in Northern Portugal: First Findings”, Published on Acta Med Port 2022 Mar;35(3):164-169.
by: Hugo Monteiro, et al.
Published: (2022-03-01)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
by: Chengxing Wang, et al.
Published: (2021-07-01)

Factors for effective colorectal cancer screening
by: Davorin Dajčman
Published: (2006-12-01)

ADVANCES IN FAECAL DNA TESTING FOR COLORECTAL CANCER SCREENING: A LITERATURE REVIEW FOR PRIMARY CARE PROVIDERS
by: Louise Babikow, et al.
Published: (2018-03-01)

Physician‐office vs home uptake of colorectal cancer screening using FOBT/FIT among screening‐eligible US adults
by: Onyema Greg Chido‐Amajuoyi, et al.
Published: (2019-12-01)

Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study
by: Cecilia Högberg, et al.
Published: (2020-07-01)

Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian randomisation study
by: Tung Hoang, et al.
Published: (2024-09-01)

Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer
by: Louise Olsson, et al.
Published: (2023-06-01)

Feedback and training tool to improve provision of preventive care by physicians using EMRs: a randomised control trial
by: Heather Maddocks, et al.
Published: (2011-06-01)

Fecal occult blood testing in colorectal cancer screening programs
by: N. V. Severskaya, et al.
Published: (2022-09-01)

Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study
by: Jayne Digby, et al.
Published: (2019-12-01)

Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study
by: Ru-chen Zhou, et al.
Published: (2021-10-01)

Early detection of Haemonchus contortus infection in sheep using three different faecal occult blood tests
by: A.V. Rodríguez, et al.
Published: (2015-07-01)

Risk for Colorectal Cancer in Patients with Serially Positive Fecal Immunochemistry Test in an Annual Screening Program
by: Takuji Kawamura, et al.
Published: (2021-10-01)